Scope Biosciences closed a funding round (amount undisclosed) in Jun 2025. The company is based in Wageningen, Netherlands. Investors in the round: Oost NL, SHIFT Invest. Data as of 21 Sept 2026.
Amount undisclosed or unconverted.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
